This inventor holds 4 USPTO granted patents and 3 EPO patents. Top assignees: Innovative Pharmacology Research Ooo (Iphar), Obschestvo S Ogranichennoy Otvetstvennostyu “Polyar” (Ooo Polyar), Proton Ooo. Active years: 2013-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2 
1 out of 1 
1 out of 1 Years Active: 2013-2016
Title: Vladimir Grigorevich Granik: Innovator in Pharmaceutical Chemistry
Introduction
Vladimir Grigorevich Granik is a notable inventor based in Moscow, Russia. He has made significant contributions to the fields of chemical and pharmaceutical industries, particularly in the development of compounds for treating cardiovascular diseases and anti-inflammatory agents. With a total of 4 patents, Granik's work showcases his dedication to advancing medical science.
Latest Patents
One of Granik's latest patents is an antithrombotic and antiatherosclerotic agent and method for producing the same. This invention focuses on compounds that can be utilized in the treatment of cardiovascular diseases. The proposed compound, 2-[2-cyano-2-[5-(hydroxymethyl)-3-methyl-1,3-oxazolidin-2-ylidene]ethylidene]indolin-3-one, exhibits properties as an exogenous nitric oxide donor and a platelet aggregation inhibitor. It also demonstrates antihypertensive activity and activates the soluble guanylate cyclase enzyme. Variants of methods for synthesizing this compound are also included in the patent.
Another significant patent by Granik is for a biologically active compound known as N-[3-(4-nitrophenylamino)-indole-2-ilmethylene]aminoguanidine hydrochloride. This compound has anti-inflammatory and chondroprotective activity, making it a valuable addition to the pharmaceutical arsenal. Notably, it does not exhibit adverse effects, which is a critical consideration in drug development.
Career Highlights
Throughout his career, Granik has worked with various companies, including Proton OOO and Polyar LLC. His experience in these organizations has contributed to his expertise in pharmaceutical chemistry and innovation.
Collaborations
Granik has collaborated with notable individuals in his field, including Valery Aleksandrovich Parshin and Svetlana Yurevna Ryabova. These collaborations have likely enriched his research and development efforts.
Conclusion
Vladimir Grigorevich Granik stands out as an influential inventor in the pharmaceutical industry. His innovative patents and contributions to medical science reflect his commitment to improving health outcomes through research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile